APYX News and Press, Apyx Medical Corporation

Body by Apyx Takes Center Stage at Miami Swim Week Showcasing Real Patient Transformations and Confidence on the Runway PR Newswire CLEARWATER, Fla. , May 27, 2026 /PRNewswire/ -- Apyx Medica l  Corporation (NASDAQ:APYX) ("Apyx Medical" or the "Company"), the leade...

CLEARWATER, Fla., May 21, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics products marketed and sold as Renuvion ® and the AYON Body Contouring System™ (AYON), today an...

CLEARWATER, Fla., May 14, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion ®  and the AYON Body Contouring System™ (AYON)...

CLEARWATER Fla., May 11, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics products marketed and sold as Renuvion ® and the AYON Body Contouring System™ (AYON), today ann...

2026-05-08 11:16:55 ET Image source: The Motley Fool. Thursday, May 7, 2026 at 8 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-05-07 19:12:10 ET More on Apyx Medical Apyx Medical Corporation (APYX) Q1 2026 Earnings Call Transcript Apyx Medical Corporation (APYX) Q4 2025 Earnings Call Transcript Apyx Medical GAAP EPS of -$0.05 beats by $0.06, revenue of $12.5M beats by $1.73M Apy...

2026-05-07 19:11:17 ET Apyx Medical Corporation (APYX) Q1 2026 Earnings Call May 7, 2026 8:00 AM EDT Company Participants Charles Goodwin - President, CEO & Director Matthew Hill - CFO, Treasurer & Secretary ... Read the full article on Seeking Alpha ...

2026-05-07 08:42:39 ET More on Apyx Medical Apyx Medical Corporation (APYX) Q4 2025 Earnings Call Transcript Apyx Medical outlines 9%–11% revenue growth target for 2026 as AYON launch accelerates Apyx Medical GAAP EPS of -$0.03 beats by $0.03, revenue of $19.1...

Reported total revenue of $12.5 million in the first quarter of 2026 primarily driven by 36% growth in the Surgical Aesthetics segment Raised total revenue guidance for FY2026 to a range of $59.0 million to $60.0 million Management to host a conference call today at 8:00 a.m. ET CLEARW...

CLEARWATER, Fla., April 23, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion ® and the AYON Body Contouring System ™ (AYON), today ann...